# MitoChem Therapeutics, Inc. — Form D/A

MitoChem Therapeutics, Inc. of CHARLESTON, SC, a company, filed a Form D amendment with the SEC on 2020-12-18. The offering totals $300K, of which $236K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-12-18
- Form: D/A
- Accession: 0001836268-20-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $236K
- Remaining: $64K
- Investors: 7
- Date of first sale: 2020-12-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-383566

## Issuer

- Name: MitoChem Therapeutics, Inc.
- CIK: 0001836268
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Address: 624 MEETING STREET, CHARLESTON, SC, 29403
- Phone: 520-204-5552

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Gyda Caren Beeson | Director | Charleston, SC |
| Baerbel G Rohrer | Director | Charleston, SC |
| Rick G Schnellman | Director | Charleston, SC |
| Michael Voevodsky | Director | Tucson, AZ |
| Michael Voevodsky | Executive Officer | Tucson, AZ |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-12-17](https://search.stillhousedata.com/formd/0001836268-20-000002) | D | $300K | $236K |

## More

- [CIK 1836268 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1836268&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001836268-20-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.